StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
26
Publishing Date
2022 - 06 - 22
1
2022 - 05 - 09
1
2022 - 05 - 05
1
2022 - 04 - 27
1
2022 - 04 - 20
1
2022 - 03 - 25
1
2022 - 02 - 28
1
2022 - 02 - 16
1
2022 - 01 - 25
1
2022 - 01 - 24
1
2021 - 12 - 16
1
2021 - 12 - 13
1
2021 - 11 - 22
1
2021 - 11 - 19
1
2021 - 10 - 21
2
2021 - 10 - 12
1
2021 - 09 - 22
2
2021 - 09 - 08
1
2021 - 08 - 03
1
2021 - 08 - 02
2
2021 - 07 - 28
1
2021 - 07 - 26
1
2021 - 05 - 03
1
Sector
Health technology
26
Tags
Alliances
1
Als
1
Antibody
2
Approval
5
Arct-154
5
Biopharma
1
Biotech-beach
9
Ceo
1
Ces
1
Clinical trials
1
Clinical-trials-phase-ii
4
Clinical-trials-phase-iii
1
Collaboration
2
Conference
2
Covid
2
Covid-19
1
Disease
1
Earnings
2
Employment compensation
1
Events
1
Expansion
1
Financial results
3
Grant
3
Granted
2
Money
2
Mrna
1
Nasdaq
1
People
1
Pharmaceutical
1
Phase 1
1
Phase 2
2
Phase 3
3
Pons
2
Rare
1
Report
3
Research
4
Response
2
Results
5
Sars-cov-2
6
Therapeutics
12
Trial
6
Trials
1
Vaccine
7
Entities
Abbott laboratories
10
Abbvie inc.
31
Adma biologics inc
4
Adverum biotechnologies, inc.
2
Agios pharmaceuticals, inc.
2
Alnylam pharmaceuticals, inc.
2
Altria group
2
Amgen inc.
23
Amicus therapeutics, inc.
2
Arcturus therapeutics holdings inc.
26
Arrowhead pharmaceuticals, inc.
12
Astellas pharma inc
14
Astrazeneca plc
29
Avalonbay communities, inc.
2
Bausch health companies inc.
7
Baxter international inc.
5
Biocryst pharmaceuticals, inc.
2
Biogen inc.
6
Bristol-myers squibb company
43
Catalent, inc.
3
Centogene n.v.
5
Codexis, inc.
3
Csl ltd
4
Eli lilly and company
42
Exelixis, inc.
27
Genmab a/s
3
Gilead sciences, inc.
15
Glaxosmithkline plc
34
Global blood therapeutics, inc.
3
Grifols, s.a.
6
Hutchison china meditech limited
7
Immunogen, inc.
3
Incyte corporation
16
Jazz pharmaceuticals plc
6
Johnson & johnson
82
Karyopharm therapeutics inc.
7
Logicbio therapeutics, inc.
4
Macrogenics, inc.
4
Mallinckrodt plc
4
Moderna, inc.
5
Morphosys ag
13
Nektar therapeutics
3
Neurocrine biosciences, inc.
10
Novartis ag
58
Novavax, inc.
4
Novo nordisk a/s
15
Orange
4
Ovid therapeutics inc.
6
Pfizer, inc.
23
Regeneron pharmaceuticals, inc.
6
Sanofi
60
Takeda pharmaceutical company limited
424
Teva pharmaceutical industries limited
5
Teva pharmaceutical industries ltd
20
Thermo fisher scientific inc
7
Ucb s.a.
8
Vericel corporation
3
Vertex pharmaceuticals incorporated
4
Viatris inc.
7
Xencor, inc.
12
Symbols
ABBV
1
ALKS
1
AMGN
1
AQST
1
ARCT
70
ASC
1
AZN
1
BELFA
1
BELFB
1
BNTX
3
BRSYF
1
BWAY
1
CCAP
1
CNC
1
CTLT
1
CVAC
2
DESP
1
DHI
1
ENIC
1
EPRT
1
ESEA
1
FCNCA
1
FITB
1
FNCTF
1
GLAXF
1
GSK
2
HALO
1
ITRN
1
JNJ
32
KRYS
2
LAAOF
1
LGND
1
LI
1
LMB
1
MGNX
1
MRNA
3
NVAX
1
NVS
1
PAGS
1
PAM
1
PARR
1
PGTI
1
QURE
1
RCMT
1
RGA
1
SILV
1
SLVM
1
SNY
2
SNYNF
1
SPOK
1
SRRK
1
STNE
1
STNG
1
SYF
1
TAK
26
TFFP
1
TMO
1
TNK
1
VERV
1
VST
1
Exchanges
Nasdaq
26
Nyse
26
Crawled Date
2022 - 06 - 22
1
2022 - 05 - 09
1
2022 - 05 - 05
1
2022 - 04 - 27
1
2022 - 04 - 20
1
2022 - 03 - 25
1
2022 - 02 - 28
1
2022 - 02 - 16
1
2022 - 01 - 25
1
2022 - 01 - 24
1
2021 - 12 - 16
1
2021 - 12 - 13
1
2021 - 11 - 22
1
2021 - 11 - 19
1
2021 - 10 - 21
2
2021 - 10 - 12
1
2021 - 09 - 22
2
2021 - 09 - 08
1
2021 - 08 - 03
1
2021 - 08 - 02
2
2021 - 07 - 28
1
2021 - 07 - 26
1
2021 - 05 - 03
1
Crawled Time
09:00
2
10:00
1
12:00
4
12:20
1
13:00
4
13:30
3
14:00
5
14:20
1
15:00
1
21:00
1
22:00
1
23:00
2
Source
www.biospace.com
26
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Arcturus therapeutics holdings inc.
symbols :
TAK
save search
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 22, 2022
Published:
2022-06-22
(Crawled : 09:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-0.45%
|
O:
1.28%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-12.73%
|
O:
1.36%
H:
0.0%
C:
0.0%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
91.35%
|
O:
-0.64%
H:
14.95%
C:
10.14%
nasdaq
grant
therapeutics
employment compensation
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
Published:
2022-05-09
(Crawled : 21:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-9.32%
|
O:
-0.69%
H:
0.28%
C:
-1.1%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-15.49%
|
O:
0.15%
H:
0.0%
C:
0.0%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
44.12%
|
O:
-2.88%
H:
2.34%
C:
-8.64%
therapeutics
Arcturus Reports Strong Three-Month Durability Results from ARCT-154 Booster Trial
Published:
2022-05-05
(Crawled : 13:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-9.07%
|
O:
0.55%
H:
0.0%
C:
-1.16%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-16.86%
|
O:
0.72%
H:
0.0%
C:
0.0%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
30.72%
|
O:
6.93%
H:
1.13%
C:
-8.47%
arct-154
trial
results
Arcturus Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 9, 2022
Published:
2022-04-27
(Crawled : 12:20)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-8.76%
|
O:
-0.76%
H:
0.66%
C:
0.28%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-20.47%
|
O:
-0.77%
H:
0.0%
C:
0.0%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
27.32%
|
O:
-6.84%
H:
1.52%
C:
-3.65%
report
therapeutics
results
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
Published:
2022-04-20
(Crawled : 12:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-8.57%
|
O:
1.17%
H:
0.68%
C:
0.27%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-17.85%
|
O:
1.06%
H:
1.14%
C:
0.91%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
7.06%
|
O:
-20.04%
H:
28.04%
C:
21.44%
covid-19
arct-154
vaccine
mrna
phase 3
Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
Published:
2022-03-25
(Crawled : 14:20)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-11.56%
|
O:
-0.53%
H:
0.57%
C:
0.34%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-15.13%
|
O:
0.65%
H:
0.0%
C:
0.0%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
-3.92%
|
O:
0.0%
H:
0.0%
C:
-3.21%
rare
therapeutics
disease
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
Published:
2022-02-28
(Crawled : 22:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-11.51%
|
O:
0.54%
H:
1.66%
C:
1.13%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-7.4%
|
O:
1.79%
H:
0.0%
C:
0.0%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
14.13%
|
O:
-0.93%
H:
3.16%
C:
2.35%
ces
therapeutics
Arcturus Therapeutics to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022
Published:
2022-02-16
(Crawled : 14:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-12.9%
|
O:
-0.07%
H:
0.59%
C:
0.53%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-11.46%
|
O:
-0.49%
H:
0.81%
C:
0.43%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
8.57%
|
O:
-2.58%
H:
1.98%
C:
1.07%
financial results
therapeutics
report
results
Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster Clinical Trial
Published:
2022-01-25
(Crawled : 13:30)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-8.63%
|
O:
-0.76%
H:
2.02%
C:
1.04%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-9.1%
|
O:
-0.37%
H:
3.73%
C:
3.25%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
8.35%
|
O:
0.24%
H:
4.13%
C:
1.44%
arct-154
trial
therapeutics
response
sars-cov-2
report
pons
antibody
Arcturus Therapeutics Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses to SARS-CoV-2 and Several Variants
Published:
2022-01-24
(Crawled : 14:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-8.19%
|
O:
1.18%
H:
0.34%
C:
-0.69%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-10.75%
|
O:
-1.19%
H:
0.1%
C:
-0.63%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
7.47%
|
O:
-2.85%
H:
3.12%
C:
2.09%
arct-154
trial
therapeutics
response
sars-cov-2
pons
antibody
Arcturus Therapeutics Reports New Data and Provides Additional Updates from ARCT-154 and ARCT-165 Clinical Trials
Published:
2021-12-16
(Crawled : 14:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-2.29%
|
O:
1.18%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-12.95%
|
O:
0.59%
H:
0.0%
C:
0.0%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
-21.48%
|
O:
10.59%
H:
17.58%
C:
13.16%
arct-154
als
trials
trial
therapeutics
clinical trials
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
Published:
2021-12-13
(Crawled : 13:30)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-2.51%
|
O:
-0.59%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-10.63%
|
O:
-0.41%
H:
0.0%
C:
0.0%
KRYS
|
News
|
$159.05
-1.85%
-1.88%
240K
|
Health Technology
|
120.81%
|
O:
-1.65%
H:
0.0%
C:
0.0%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
-27.36%
|
O:
-6.92%
H:
0.0%
C:
0.0%
therapeutics
Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference
Published:
2021-11-22
(Crawled : 13:30)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-5.8%
|
O:
-1.03%
H:
0.14%
C:
-0.65%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-9.13%
|
O:
-1.22%
H:
1.0%
C:
-0.83%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
-27.7%
|
O:
-2.88%
H:
1.38%
C:
-1.52%
conference
therapeutics
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Nov 19, 2021
Published:
2021-11-19
(Crawled : 10:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-6.04%
|
O:
-0.25%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-8.78%
|
O:
0.38%
H:
0.0%
C:
0.0%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
-28.61%
|
O:
-1.26%
H:
0.0%
C:
0.0%
granted
grant
Arcturus Therapeutics Announces Leadership Appointments
Published:
2021-10-21
(Crawled : 13:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-6.44%
|
O:
-0.28%
H:
0.07%
C:
-0.57%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-9.55%
|
O:
0.32%
H:
0.05%
C:
-0.55%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
-38.42%
|
O:
-0.23%
H:
3.07%
C:
1.97%
therapeutics
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Oct 21, 2021
Published:
2021-10-21
(Crawled : 09:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-6.44%
|
O:
-0.28%
H:
0.07%
C:
-0.57%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-9.55%
|
O:
0.32%
H:
0.05%
C:
-0.55%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
-38.42%
|
O:
-0.23%
H:
3.07%
C:
1.97%
granted
grant
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 3b Study for ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
Published:
2021-10-12
(Crawled : 13:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-6.96%
|
O:
0.21%
H:
0.14%
C:
-1.05%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-7.56%
|
O:
-0.16%
H:
0.11%
C:
-1.44%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
-37.23%
|
O:
4.89%
H:
1.6%
C:
-1.84%
vaccine
phase 3
approval
sars-cov-2
Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of Vingroup to Discuss Expansion of COVID-19 Vaccine Collaboration
Published:
2021-09-22
(Crawled : 23:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-23.17%
|
O:
-0.17%
H:
0.0%
C:
-1.11%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-9.96%
|
O:
0.5%
H:
0.36%
C:
-0.86%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
-47.93%
|
O:
1.81%
H:
2.1%
C:
-0.32%
covid
expansion
collaboration
vaccine
ceo
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
Published:
2021-09-22
(Crawled : 12:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-23.17%
|
O:
-0.17%
H:
0.0%
C:
-1.11%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-9.96%
|
O:
0.5%
H:
0.36%
C:
-0.86%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
-47.93%
|
O:
1.81%
H:
2.1%
C:
-0.32%
phase 2
vaccine
phase 3
approval
sars-cov-2
Arcturus Therapeutics to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021
Published:
2021-09-08
(Crawled : 14:00)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-22.5%
|
O:
0.76%
H:
0.06%
C:
-0.35%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-14.03%
|
O:
-0.41%
H:
0.79%
C:
0.16%
ARCT
4
|
$26.98
-3.4%
-3.44%
270K
|
Health Technology
|
-52.25%
|
O:
-0.9%
H:
1.36%
C:
-0.68%
biopharma
conference
← Previous
1
2
Next →
Gainers vs Losers
61%
39%
Top 10 Gainers
CSSE
4
|
$0.4253
179.25%
64.77%
210M
|
Consumer Services
BOF
|
$2.08
77.78%
41.21%
110M
|
ILAG
|
$0.54
12.27%
40.62%
3.7M
|
LICN
|
$0.999
78.39%
40.49%
15M
|
AMST
|
$3.4
70.0%
39.58%
70M
|
Technology Services
MTC
|
$3.6
60.71%
38.04%
9.1M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.458
14.5%
30.92%
91K
|
Health Services
WHLM
|
$6.25
35.87%
28.46%
700K
|
Commercial Services
MULN
|
News
|
$3.77
38.1%
27.78%
13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.